6533b82efe1ef96bd1292a24
RESEARCH PRODUCT
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.
Massimo MidiriFederica VernuccioTommaso Vincenzo BartolottaFrancesco AgnelloDario PiconeMassino GaliaMarco Dioguardi BurgioRoberto LagallaAdele TaibbiAntonino AgrusaGiuseppe BrancatelliGiuseppe CabibboLydia Giannitrapanisubject
Gadolinium DTPALiver CirrhosisGadoxetic acidCirrhotic livermedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisCarcinoma HepatocellularGadoxetic acidContrast MediaGastroenterology030218 nuclear medicine & medical imagingResection03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansIn patientTopic HighlightSettore MED/12 - GastroenterologiaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyHepatobiliary contrast materialMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSettore MED/18 - Chirurgia GeneraleLiver030220 oncology & carcinogenesisHepatobiliary phaseLiver functionSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging; Gastroenterologymedicine.drugdescription
Gadoxetic acid improves detection and characterization of focal liver lesions in cirrhotic patients and can estimate liver function in patients undergoing liver resection. The purpose of this article is to describe the optimal gadoxetic acid study protocol for the liver, the unique characteristics of gadoxetic acid, the differences between gadoxetic acid and extra-cellular gadolium chelates, and the differences in phases of enhancement between cirrhotic and normal liver using gadoxetic acid. We also discuss how to obtain and recognize an adequate hepatobiliary phase.
year | journal | country | edition | language |
---|---|---|---|---|
2015-05-16 | World journal of gastroenterology |